3.1. Study Population
A total of 10 subjects were selected based on the inclusion and exclusion criteria described in the materials and methods section. The average interval between visits in the treatment period was 23.22 ± 3.32 days between baseline (V1) and V2, 12.12 ± 3.36 days between V2 and V3, and 31.89 ± 5.52 days between V3 and V4 (